Thrift AP, Nguyen TH. Gastric cancer epidemiology. Gastrointestinal Endoscopy Clinics. 2021;31(3):425–39.

Article  PubMed  Google Scholar 

Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, Meheus F, Verhoeven RH. Vignat Jo, Laversanne M. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: a population-based modelling study. EClinicalMedicine. 2022;47:101404.

Article  PubMed  PubMed Central  Google Scholar 

Shuai Y, Li C, Zhou X. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis. Clin Transl Oncol. 2020;22(9):1580–90.

Article  CAS  PubMed  Google Scholar 

Tseng CH. The relationship between diabetes mellitus and gastric cancer and the potential benefits of metformin: an extensive review of the literature. Biomolecules. 2021;11(7).

Ohkuma T, Peters SAE, Woodward M. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events. Diabetologia. 2018;61(10):2140–54.

Article  PubMed  PubMed Central  Google Scholar 

Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol (Lausanne). 2020;11:191.

Article  PubMed  Google Scholar 

Chung WS, Le PH, Kuo CJ, Chen TH, Kuo CF, Chiou MJ, Chou WC, Yeh TS, Hsu JT. Impact of metformin use on survival in patients with gastric cancer and diabetes mellitus following gastrectomy. Cancers (Basel). 2020;12(8).

Yuan M, Han S, Jia Y, Feng J, Liu D, Su Z, Liu X. Statins are associated with improved survival of patients with gastric cancer: a systematic review and meta-analysis. Int J Clin Pract. 2022;2022:4938539.

Article  PubMed  PubMed Central  Google Scholar 

Seo HS, Jung YJ, Kim JH, Lee HH, Park CH. The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus. Am J Clin Oncol. 2019;42(12):909–17.

Article  CAS  PubMed  Google Scholar 

Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care. 2012;35(2):299–304.

Article  PubMed  PubMed Central  Google Scholar 

Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer. Aging (Albany NY). 2019;11(17):7197–205.

Article  CAS  PubMed  Google Scholar 

Baglia ML, Cui Y, Zheng T, Yang G, Li H, You M, Xu L, Murff H, Gao YT, Zheng W, et al. Diabetes medication use in association with survival among patients of breast, colorectal, lung, or gastric cancer. Cancer Res Treat. 2019;51(2):538–46.

Article  CAS  PubMed  Google Scholar 

Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2(1):1–12.

Penson D, Krishnaswami S, Jules A. Newcastle-Ottawa quality assessment form for cohort studies. 2012. In. 2018.

Lee CK, Jung M, Jung I, Heo SJ, Jeong YH, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, et al. Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy. Ann Surg. 2016;263(1):96–102.

Article  PubMed  Google Scholar 

Lacroix O, Couttenier A, Vaes E, Cardwell CR, De Schutter H, Robert A. Impact of metformin on gastric adenocarcinoma survival: a Belgian population based study. Cancer Epidemiol. 2018;53:149–55.

Article  PubMed  Google Scholar 

Chen X, Chen Y, Li T, Jun L, Lin T, Hu Y, Huang H, Chen H, Liu H, Li T, et al. Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy. Chin J Cancer Res. 2020;32(5):631–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho MH, Yoo TG, Jeong SM, Shin DW. Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: a nationwide cohort study. Cancer Prev Res (Phila). 2021;14(1):95–104.

Article  CAS  PubMed  Google Scholar 

Li P, Zhang C, Gao P, Chen X, Ma B, Yu D, Song Y, Wang Z. Metformin use and its effect on gastric cancer in patients with type 2 diabetes: a systematic review of observational studies. Oncol Lett. 2018;15(1):1191–9.

PubMed  Google Scholar 

Chung W-S, Le P-H, Kuo C-J, Chen T-H, Kuo C-F, Chiou M-J, Chou W-C, Yeh T-S, Hsu J-T. Impact of metformin use on survival in patients with gastric cancer and diabetes mellitus following gastrectomy. Cancers. 2020;12(8):2013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou X-L, Xue W-H, Ding X-F, Li L-F, Dou M-M, Zhang W-J, Lv Z, Fan Z-R, Zhao J, Wang L-X. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies. Oncotarget. 2017;8(33):55622.

Article  PubMed  PubMed Central  Google Scholar 

Ma S-J, Zheng Y-X, Zhou P-C, Xiao Y-N, Tan H-Z. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis. Oncotarget. 2016;7(40):66202.

Article  PubMed  PubMed Central  Google Scholar 

Zhou P-T, Li B, Liu F-R, Zhang M-C, Wang Q, Li Y-Y, Xu C, Liu Y-H, Yao Y, Li D. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Oncotarget. 2017;8(15):25242.

Article  PubMed  PubMed Central  Google Scholar 

Hu J, Chen J-B, Cui Y, Zhu Y-W, Ren W-b, Zhou X, Liu L-F, Chen H-Q, Zu X-B. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Medicine. 2018;97(30).

Guo J, Xu K, An M, Zhao Y. Metformin and endometrial cancer survival: a quantitative synthesis of observational studies. Oncotarget. 2017;8(39):66169.

Article  PubMed  PubMed Central  Google Scholar 

Bahardoust M, Yarali M, Donyadideh G, Rahimi E, Naderi D, Tehrani FM, Delpisheh A. The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies. BMC Musculoskelet Disord. 2023;24(1):1–11.

Article  Google Scholar 

Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, Szabo E. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res. 2014;7(9):867–85.

Article  CAS  Google Scholar 

Saraei P, Asadi I, Kakar MA, Moradi-Kor N. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer management and research. 2019;11:3295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang J, Jeong S-M, Shin DW, Cho M, Cho JH, Kim J. The associations of aspirin, statins, and metformin with lung cancer risk and related mortality: a time-dependent analysis of population-based nationally representative data. J Thorac Oncol. 2021;16(1):76–88.

Article  CAS  PubMed  Google Scholar 

Greenhill C. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer. Nat Rev Gastroenterol Hepatol. 2015;12(3):124.

Article  PubMed  Google Scholar 

Cheung KS, Chan EW, Wong AY, Chen L, Seto WK, Wong IC, Leung WK. Metformin use and gastric cancer risk in diabetic patients after Helicobacter pylori eradication. JNCI: Journal of the National Cancer Institute. 2019;111(5):484–9.

Quinn BJ, Kitagawa H, Memmott RM, Gills JJ, Dennis PA. Repositioning metformin for cancer prevention and treatment. Trends Endocrinol Metab. 2013;24(9):469–80.

Article  CAS  PubMed  Google Scholar 

Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Can Res. 2009;69(19):7507–11.

Article  CAS  Google Scholar 

Kato K, Gong J, Iwama H, Kitanaka A, Tani J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther. 2012;11(3):549–60.

Article  CAS  PubMed  Google Scholar 

Wu P, Tang Y, Fang X, Xie C, Zeng J, Wang W, Zhao S. Metformin suppresses hypopharyngeal cancer growth by epigenetically silencing long non-coding RNA SNHG7 in FaDu cells. Front Pharmacol. 2019;10:143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006;66:10269–73.

Article  CAS  PubMed  Google Scholar